Cryocell International Stock Short Ratio
| CCEL Stock | USD 8.45 0.65 8.33% |
CryoCell International fundamentals help investors to digest information that contributes to CryoCell International's financial success or failures. It also enables traders to predict the movement of CryoCell Stock. The fundamental analysis module provides a way to measure CryoCell International's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CryoCell International stock.
CryoCell |
CryoCell International Company Short Ratio Analysis
CryoCell International's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current CryoCell International Short Ratio | 1.18 X |
Most of CryoCell International's fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CryoCell International is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, CryoCell International has a Short Ratio of 1.18 times. This is 69.74% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The short ratio for all United States stocks is 70.5% higher than that of the company.
CryoCell Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CryoCell International's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CryoCell International could also be used in its relative valuation, which is a method of valuing CryoCell International by comparing valuation metrics of similar companies.CryoCell International is currently under evaluation in short ratio category among related companies.
CryoCell Fundamentals
| Return On Equity | 1.29 | ||||
| Return On Asset | -0.0093 | ||||
| Profit Margin | (0.31) % | ||||
| Operating Margin | 0.10 % | ||||
| Current Valuation | 78.98 M | ||||
| Shares Outstanding | 8.1 M | ||||
| Shares Owned By Insiders | 47.21 % | ||||
| Shares Owned By Institutions | 10.80 % | ||||
| Number Of Shares Shorted | 9.45 K | ||||
| Price To Earning | 10.76 X | ||||
| Price To Book | 9.72 X | ||||
| Price To Sales | 1.91 X | ||||
| Revenue | 31.34 M | ||||
| Gross Profit | 21.54 M | ||||
| EBITDA | 5.2 M | ||||
| Net Income | (9.52 M) | ||||
| Cash And Equivalents | 2.96 M | ||||
| Cash Per Share | 0.35 X | ||||
| Total Debt | 10.9 M | ||||
| Debt To Equity | 0.26 % | ||||
| Current Ratio | 0.47 X | ||||
| Book Value Per Share | (1.25) X | ||||
| Cash Flow From Operations | 8.92 M | ||||
| Short Ratio | 1.18 X | ||||
| Earnings Per Share | (1.16) X | ||||
| Target Price | 9.0 | ||||
| Number Of Employees | 82 | ||||
| Beta | 0.55 | ||||
| Market Capitalization | 68.48 M | ||||
| Total Asset | 61.22 M | ||||
| Retained Earnings | (31.16 M) | ||||
| Working Capital | (11.41 M) | ||||
| Current Asset | 6.08 M | ||||
| Current Liabilities | 2.82 M | ||||
| Net Asset | 61.22 M |
About CryoCell International Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CryoCell International's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CryoCell International using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CryoCell International based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards CryoCell International in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, CryoCell International's short interest history, or implied volatility extrapolated from CryoCell International options trading.
Pair Trading with CryoCell International
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CryoCell International position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CryoCell International will appreciate offsetting losses from the drop in the long position's value.Moving against CryoCell Stock
| 0.77 | EGRX | Eagle Pharmaceuticals | PairCorr |
| 0.71 | EXAI | Exscientia ADR Upward Rally | PairCorr |
| 0.69 | ETON | Eton Pharmaceuticals Financial Report 9th of May 2024 | PairCorr |
| 0.66 | EVOK | Evoke Pharma | PairCorr |
| 0.6 | ELAN | Elanco Animal Health Financial Report 14th of May 2024 | PairCorr |
The ability to find closely correlated positions to CryoCell International could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CryoCell International when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CryoCell International - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CryoCell International to buy it.
The correlation of CryoCell International is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CryoCell International moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CryoCell International moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CryoCell International can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out CryoCell International Piotroski F Score and CryoCell International Altman Z Score analysis. For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.Note that the CryoCell International information on this page should be used as a complementary analysis to other CryoCell International's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for CryoCell Stock analysis
When running CryoCell International's price analysis, check to measure CryoCell International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CryoCell International is operating at the current time. Most of CryoCell International's value examination focuses on studying past and present price action to predict the probability of CryoCell International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CryoCell International's price. Additionally, you may evaluate how the addition of CryoCell International to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |
Is CryoCell International's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CryoCell International. If investors know CryoCell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CryoCell International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of CryoCell International is measured differently than its book value, which is the value of CryoCell that is recorded on the company's balance sheet. Investors also form their own opinion of CryoCell International's value that differs from its market value or its book value, called intrinsic value, which is CryoCell International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CryoCell International's market value can be influenced by many factors that don't directly affect CryoCell International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CryoCell International's value and its price as these two are different measures arrived at by different means. Investors typically determine if CryoCell International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CryoCell International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.